Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Finasteride increases hair weight and count in men with hair loss, with best results after four years.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Certain drugs that block specific enzymes can help treat prostate diseases.